Project Grant R01NR022129
- The National Institute of Nursing Research awarded The Trustees of The University of Pennsylvania $4,241,658 on January 29, 2026, under the Nursing Research program (CFDA 93.361) to evaluate multi-level interventions addressing nurse burnout across hospital settings. The study employs a repeated cross-sectional design spanning 20 years of data collection from approximately 535 hospitals in California, Florida, New Jersey, and Pennsylvania. Data collection timepoints occur at 2006, 2016, 2024,...
- The National Institute of Nursing Research awarded the University of Pennsylvania $3,002,821 on January 30, 2026, under the Nursing Research program (CFDA 93.361) to investigate which interventions most effectively reduce hospital nurse burnout. The research will examine the relationship between organizational and individual interventions implemented nationwide to address nurse burnout and their effectiveness in reducing burnout at the hospital and individual nurse levels. The study integrates...
- The National Institute of Nursing Research awarded the University of Pennsylvania $406,250 on August 21, 2026, under the Nursing Research program (CFDA 93.361) to evaluate the impact of the nurse work environment on outcomes for hospitalized older adults living with Alzheimer's disease and related dementias. The recipient will conduct a mixed-methods sequential explanatory study examining modifiable organizational features central to care quality, including nurse autonomy and authority to...
- The National Institute of Nursing Research awarded the University of Pennsylvania $630,385 for project grant R01NR022346 on August 21, 2026, under the Nursing Research program (CFDA 93.361). The award funds a multi-year investigation into workplace violence exposures among registered nurses across hospitals and the organizational factors driving variation in such exposures. The research comprises three specific aims: determining whether and to what extent internal and external organizational...
- The National Institute of Nursing Research awarded Johns Hopkins University $2.437 million on September 15, 2025 under the Nursing Research program (CFDA 93.361) to evaluate the effectiveness of an integrated group postpartum and well-child care model on maternal and child health outcomes in low-resource settings. The award funds a cluster randomized control trial testing a model that brings together 8–10 postpartum women with similarly aged infants for integrated care extending to 12 months...
- The National Institute of Nursing Research awarded New York University $2,341,029 on September 26, 2025, under the Nursing Research program (CFDA 93.361) to develop a community-driven innovation agenda for preventing severe maternal morbidity and related serious complications of pregnancy and postpartum. The project conducts mixed-methods research using in-depth interviews and surveys with survivors of severe maternal morbidity (SMM), their partners, family members, and support persons to...
- The Department of Health and Human Services National Institutes of Health National Institute of Nursing Research awarded $6,554,392 to The Johns Hopkins University on July 1, 2026, under the Nursing Research program (CFDA 93.361) to conduct an intersectional mixed methods study examining how structural gendered racism-related policies impact depression and anxiety among US- and foreign-born Black, Latina, and White women. The research uses novel theoretical frameworks including...
- The National Institute of Nursing Research awarded The Johns Hopkins University $1,864,616 on September 26, 2025, under the Nursing Research program (CFDA 93.361) to conduct a hybrid effectiveness-implementation research study evaluating community-based doula support for American Indian maternal health outcomes. The project, "Ama Bidziil (Strong Mothers): Advancing American Indian Maternal Health Through Community-Based Doula Support," will assess the impact of doula services on...
- The National Institute of Nursing Research awarded the Regents of the University of Minnesota $3,585,692 on July 28, 2026, under the Nursing Research program (CFDA 93.361) to conduct a mixed-methods investigation into carework as a social determinant of health and its impact on worker well-being. The research combines quantitative analyses of national longitudinal datasets—the Panel Study of Income Dynamics and the National Health Interview Survey—with qualitative interviews of care workers to...
- The National Institute of Nursing Research awarded University of Massachusetts Medical School $7,345,938 on April 16, 2026, under the Nursing Research program (CFDA 93.361) to conduct a multi-state longitudinal study examining the effectiveness of school-based health centers to improve pediatric asthma care and advance health equity. The study will compare asthma outcomes and guideline-based care delivery in school-based health centers against traditional community health centers, focusing on...
The National Institute of Nursing Research awarded The Trustees of The University of Pennsylvania $416,321 on August 18, 2026, under the Nursing Research program (CFDA 93.361) to conduct an explanatory sequential mixed-methods study examining organizational resources that differentiate high-performing hospitals from low-performers in spontaneous vaginal birth (SVB) outcomes. The study, titled "Building on Lessons from Optimal Organizations for Maternity Outcomes" (the BLOOM Study), investigates nursing organizational resources, including work environment and staffing, that support SVB—the preferred birth outcome for most women and babies, the least expensive option, and the one associated with optimal short- and long-term health. The research compares high-performing hospitals with excellent SVB rates overall and for women from racial and ethnic minorities (who typically experience lower SVB rates) against low-performers to understand what differentiates them and to document practices and organizational factors that can inform clinical practice and policy. Work is performed in Philadelphia, Pennsylvania. The period of performance runs through May 31, 2029.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 9/3/26 | ||
| Not listed | $416.3k | 8/19/26 |